Investment analysts at UBS AG (NYSE: UBS) cut their earnings per share estimates on shares of CME Group (NYSE: CME) in a note issued to investors on Friday. The firm currently has a “buy” rating and a $300.00 target price on the company’s shares. They previously had a $330.00 target price on the stock.
Shares of CME Group traded down 1.26% during mid-day trading on Friday, hitting $265.00. CME Group has a one year low of $224.69 and a one year high of $304.61. The company has a market cap of $17.607 billion and a P/E ratio of 9.89.
The company last announced its quarterly results on Thursday, April 26th. It reported $4.02 earnings per share (EPS) for the previous quarter, missing the Thomson Reuters consensus estimate of $4.03 EPS by $0.01. The company’s quarterly revenue was down 6.9% on a year-over-year basis. On average, analysts predict that CME Group will post $4.22 earnings per share next quarter.
A number of other firms have also recently commented on CME. Analysts at ISI Group cut their price target on shares of CME Group from $285.00 to $275.00 in a research note to investors on Friday. Separately, analysts at Citigroup (NYSE: C) cut their EPS estimates on shares of CME Group in a research note on Tuesday. They now have a “buy” rating and a $300.00 price target on the stock. Finally, analysts at Jefferies Group (NYSE: JEF) raised their price target on shares of CME Group to $325.00 in a research note to investors on Wednesday, April 4th. They now have a “buy” rating on the stock.
CME Group Inc. (CME Group) offers a range of global products across all asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate.